今开:27.35 | 昨收:27.04 |
最高:29.27 | 最低:27.23 |
涨停价:0.0 | 跌停价:0.0 |
总市值:2.866205783E9 |
Corcept Therapeutics(CORT)05-02 04:15
$Corcept Therapeutics(CORT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-24-019610 Act: 34 Size: 10 MB 网页链接查看全文
Corcept Therapeutics(CORT)04-17 18:15
$Corcept Therapeutics(CORT)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001193125-24-098492 Act: 34 Size: 144 KB 网页链接查看全文
Corcept Therapeutics(CORT)02-16 04:55
$Corcept医疗(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001973251-24-000003 Act: 33 Size: 4 KB 网页链接查看全文
Corcept Therapeutics(CORT)02-16 05:25
$Corcept医疗(CORT)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-005055 Act: 34 Size: 7 MB 网页链接查看全文
Corcept Therapeutics(CORT)02-14 06:05
$Corcept医疗(CORT)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-020680 Act: 34 Size: 13 KB 网页链接查看全文
Corcept Therapeutics(CORT)02-14 09:55
$Corcept医疗(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-014883 Size: 5 KB 网页链接查看全文
Corcept Therapeutics(CORT)03-06 10:25
$Corcept医疗(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-026782 Size: 9 KB 网页链接查看全文
Corcept Therapeutics(CORT)03-06 09:45
$Corcept医疗(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-026707 Size: 11 KB 网页链接查看全文
丰硕创投04-17 17:46
$Corcept Therapeutics(CORT)$ 2024年1月2日,Corcept公司的糖皮质激素受体拮抗剂Korlym®(米非司酮),乃FDA首个批准用于治疗库欣综合征的药物,法院裁决Teva制药公司不侵犯该司专利号10195214和10842800。查看全文
Corcept Therapeutics(CORT)03-28 01:05
$Corcept医疗(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001973251-24-000008 Act: 33 Size: 6 KB 网页链接查看全文
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-059035 Size: 8 KB 网页链接
$Corcept Therapeutics(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001973251-24-000014 Act: 33 Size: 6 KB 网页链接
$Corcept Therapeutics(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001973251-24-000012 Act: 33 Size: 6 KB 网页链接
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-053847 Size: 8 KB 网页链接
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-052874 Size: 8 KB 网页链接
$Corcept Therapeutics(CORT)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001628280-24-019607 Act: 34 Size: 221 KB 网页链接
$Corcept Therapeutics(CORT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-24-019610 Act: 34 Size: 10 MB 网页链接
$Corcept Therapeutics(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-003112 Act: 33 Size: 6 KB 网页链接
$Corcept Therapeutics(CORT)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-100927 Act: 34 Size: 13 KB 网页链接
$Corcept Therapeutics(CORT)$ ARS Annual Report to Security Holders Accession Number: 0001628280-24-016598 Act: 34 Size: 11 MB 网页链接